Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Flannelly, G.
Right arrow Articles by Kitchener, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flannelly, G.
Right arrow Articles by Kitchener, H. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Faculty of Public Health Medicine of the Royal Colleges of Physicians of the United Kingdom

research-article

Immediate colposcopy or cytological surveillance for women with mild dyskaryosis: a cost effectiveness analysis


G. Flannelly, Research Registrar1,
M. K. Campbell, Senior Statistician2
P. Meldrum, Research Assistant3
D. J. Torgerson, Research Fellow4
A. Templeton, Professor, Obstetrics and Gynaecology1
H. C. Kitchener, Consulant, Obstetrics and Gynaecology1

1Department of Obstetrics and Gynaecology, Aberdeen Royal Infirmary Foresterhill, Aberdeen AB25 2ZD
2Health Services Reserch Unit, University of Aberdeen, Medical School Polwarth Building, Foresterhill, Aberdeen AB25 2ZD
3Health Economic Reasearch Unit, University of Aberdeen
4National Primary Care Research and Development Centre, Centre for Health Economics, University of York Heslington, York YO1 5DD


Address correspondence G. Finnely, at Department of Obstetrics and Gynaecology, National Maternity Hospital, Holles Street, Dublin 2, Ireland

BACKGROUND: The aim of the study was to compare the cost effectiveness of immediate diagnosis and treatment of mild dyskaryosis compared with the usual policy of cytological surveillance.

METHODS: A cost effectiveness analysis was carried out alongside a randomized clinical trial.

RESULTS: Immediate diagnosis and treatment increased total costs by 50 per cent from £54.42 per treated woman [95 per cent confidence interval (CI) £48.85–£59.98] in the surveillance group to £82.02 per woman in the immediate diagnosis and treatment group with an incremental cost of £27.60 (95 per cent CI £22.04–£33.17). However, the number of cases of CIN III detected increased by 69 per cent for the policy of immediate diagnosis and treatment. This led to an average cost effectiveness ratio of £180.18 for the immediate diagnosis and treatment group and £199.94 per case of CIN III detected for the surveillance group, with a marginal cost effectiveness ratio of £148.22 (95 per cent Cl £94.01–£309.33) for the immediate diagnosis and treatment group.

CONCLUSION: Immediate diagnosis and treatment increases the total cost of managing mildly dyskaryotic smears but this increased cost is offset by a sharp increase in the number of cases of CIN III detected.

Keywords: mild dyskaryosis, management, cost


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BMJHome page
TOMBOLA Group
Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study
BMJ, July 28, 2009; 339(jul28_2): b2549 - b2549.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.